SpringWorks Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of December 2020: 14.79x

SpringWorks Therapeutics Inc cash flow reinvestment rate. SpringWorks Therapeutics Inc (SWTX) has a Cash Flow Reinvestment Rate of 14.79x as of December 2020, reinvesting $222.84 Million (capex $54.00K plus investments $-222.78 Million) from operating cash flow of $15.07 Million. Explore SWTX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

14.79x
(Capex + Investments) / Operating CF

Total Reinvested

$222.84 Million
Capex + Investments

Operating Cash Flow

$15.07 Million
USD

Capital Expenditures

$54.00K
USD

Cash Flow Reinvestment Rate of SpringWorks Therapeutics Inc (2000–2010)

Cash flow reinvestment rate of SpringWorks Therapeutics Inc from 2000 to 2010. Historical reinvestment intensity for SpringWorks Therapeutics Inc across 9 annual periods. Explore SWTX capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

SpringWorks Therapeutics Inc Cash Flow Reinvestment Rate by Year (2000–2010)

SpringWorks Therapeutics Inc cash flow reinvestment rate by year from 2000 to 2010. Year-by-year capital reinvestment analysis for SpringWorks Therapeutics Inc. For the full cash flow conversion analysis, see SpringWorks Therapeutics Inc cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2010 0.34x $1.89 Million $5.61 Million $1.89 Million ▲ +2.1%
2009 0.33x $1.73 Million $5.23 Million $1.73 Million ▲ +274.2%
2008 0.09x $626.00K $7.10 Million $626.00K ▼ -29.3%
2007 0.12x $710.00K $5.70 Million $710.00K ▼ -92.2%
2006 1.59x $1.19 Million $748.00K $1.19 Million ▲ +733.4%
2005 0.19x $766.00K $4.01 Million $766.00K ▲ +91.7%
2004 0.10x $382.00K $3.83 Million $382.00K —
2001 0.00x $0.00 $13.79 Million $0.00 —
2000 0.00x $0.00 $1.59 Million $0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow